Moleculin to Participate in Panel at ROTH Capital's "COVID-19 Therapeutics in Development" Healthcare Event Oct 27, 2020
Moleculin Announces Independent Study Validates Annamycin's Ability to Target Lung Localized Tumors Oct 21, 2020
Moleculin Announces Additional Positive Interim Results in Adult Glioblastoma Clinical Trial Oct 13, 2020
Moleculin Announces New Antiviral Drug Candidates Demonstrate In Vitro Activity Against HIV Oct 6, 2020
Moleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at Emory University Oct 1, 2020
Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New Antimetabolites Sep 29, 2020
